Eylea Hd Clinical Trial Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eylea Hd Clinical Trial Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eylea Hd Clinical Trial Program Today - Breaking & Trending Today

EYLEA® HD (aflibercept) Injection 8 mg Two-year Results from Pivotal PULSAR Trial in Wet Age-related Macular Degeneration Presented at EURETINA

Published: October 5, 2023

First presentation of long-term results demonstrated sustained visual and anatomic improvements among EYLEA HD patients through two yearsTARRYTOWN, N.Y., Oct. 05, 2023 -- Regeneron Pharmaceuticals,...

Source: marketscreener.com

Related Topics:

United StatesMary HeatherCharlesc WykoffMark HudsonExchange CommissionEylea Hd Clinical Trial ProgramAmerican Society Of Retina SpecialistsBayer AgRegeneron Genetics CenterRegeneron Pharmaceuticals IncRetina ConsultantsAmerican SocietyRetina SpecialistsDiabetic EyeWet Age Related Macular DegenerationDiabetic Macular EdemaDiabetic RetinopathyMacular EdemaRetinal Vein OcclusionPrescribing InformationRegeneron GeneticsLooking StatementsRegeneron PharmaceuticalsProduct Candidates

EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for

Published: August 18, 2023

Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection...

Source: globenewswire.com

Related Topics:

United StatesPeter KaiserMark HudsonMary HeatherGeorged YancopoulosExchange CommissionRegeneron Genetics CenterEylea Hd Clinical Trial ProgramAmerican Academy Of OphthalmologyDrug AdministrationProfessor Of Ophthalmology At Thomas Jefferson UniversityRegeneron Pharmaceuticals IncOphthalmology ResearchCole Eye InstituteRetina Service Of Wills Eye HospitalRetina ResearchBayer AgChaney Family Endowed ChairCleveland Clinic Lerner CollegeRetina ServiceWills Eye HospitalThomas JeffersonChief Scientific OfficerAmerican AcademyDiabetic Eye